Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.
(2015) In Journal of Clinical Oncology 33(3). p.134-244- Abstract
- Olaparib is an oral poly (ADP-ribose) polymerase inhibitor with activity in germline BRCA1 and BRCA2 (BRCA1/2) -associated breast and ovarian cancers. We evaluated the efficacy and safety of olaparib in a spectrum of BRCA1/2-associated cancers.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4820289
- author
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Oncology
- volume
- 33
- issue
- 3
- pages
- 134 - 244
- publisher
- American Society of Clinical Oncology
- external identifiers
-
- pmid:25366685
- wos:000352421400008
- scopus:84921771510
- pmid:25366685
- ISSN
- 1527-7755
- DOI
- 10.1200/JCO.2014.56.2728
- language
- English
- LU publication?
- yes
- id
- 33800f58-da88-435a-8098-ae1b7e7aa410 (old id 4820289)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25366685?dopt=Abstract
- date added to LUP
- 2016-04-01 10:56:43
- date last changed
- 2022-04-28 02:35:06
@article{33800f58-da88-435a-8098-ae1b7e7aa410, abstract = {{Olaparib is an oral poly (ADP-ribose) polymerase inhibitor with activity in germline BRCA1 and BRCA2 (BRCA1/2) -associated breast and ovarian cancers. We evaluated the efficacy and safety of olaparib in a spectrum of BRCA1/2-associated cancers.}}, author = {{Kaufman, Bella and Shapira-Frommer, Ronnie and Schmutzler, Rita K and Audeh, M William and Friedlander, Michael and Balmaña, Judith and Mitchell, Gillian and Fried, Georgeta and Stemmer, Salomon M and Hubert, Ayala and Rosengarten, Ora and Steiner, Mariana and Loman, Niklas and Bowen, Karin and Fielding, Anitra and Domchek, Susan M}}, issn = {{1527-7755}}, language = {{eng}}, number = {{3}}, pages = {{134--244}}, publisher = {{American Society of Clinical Oncology}}, series = {{Journal of Clinical Oncology}}, title = {{Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.}}, url = {{http://dx.doi.org/10.1200/JCO.2014.56.2728}}, doi = {{10.1200/JCO.2014.56.2728}}, volume = {{33}}, year = {{2015}}, }